FSL-1 TFA, a toll-like receptor 2/6 (TLR2/6) agonist derived from bacteria, bolsters resistance against experimental HSV-2 infection[1] and stimulates MMP-9 production via the TLR2 and NF-kappaB/AP-1 signaling pathways in monocytic THP-1 cells[2].
Target:
MMP|||HSV|||Antibiotic|||TLR
* VAT and and shipping costs not included. Errors and price changes excepted
